News
As of Friday, Aug. 1, the moon phase is First Quarter. This phase occurs when the moon is half lit up. NASA confirms this, ...
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...
A phase 3 trial of Spine BioPharma’s chronic low back pain candidate has missed its primary endpoint. But, with the biotech pinning the failure on a “very high sham control response,” management plans ...
Joseph Paintsil scores a pair of goals and Marco Reus adds another in the second half as the Galaxy get off to a strong start ...
(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...
Fierce Pharma Asia—GSK's massive Hengrui deal; Takeda's revenue drop; Celltrion's major US plant buy
GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic erosion on Vyvanse continued to hurt Takeda. Celltrion is ...
The Greater Williamson Road Area Business Association has opened applications for phase two of its facade grant program. The initiative offers funding to help eligible Roanoke businesses upgrade their ...
The Sounders shredded CONCACAF champs Cruz Azul to open the Leagues Cup tournament Thursday night with a whopping 7-0 win at ...
Allogene Therapeutics has reported a patient death tied to its anti-CD52 monoclonal antibody used for lymphodepletion in its ...
FC Cincinnati star Evander scored the first goal of the match and assisted on two more Thursday night as FC Cincinnati defeated Monterrey 3-2 in the phase one opener of the Leagues Cup.
This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.
The Ohio Department of Development announced Wednesday the opening of a new round of grant funding to help innovators and entrepreneurs bring breakthrough technologies to the marketplace. The Ohio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results